![Caroline Baumal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Caroline Baumal
Directeur Technique/Scientifique/R&D chez
APELLIS PHARMACEUTICALS, INC.
Profil
Caroline Baumal currently works at Apellis Pharmaceuticals, Inc., as Chief Medical Officer from 2023 and New England Eye Center, as Professor.
Dr. Baumal received her doctorate degree from the University of Toronto.
Postes actifs de Caroline Baumal
| Sociétés | Poste | Début |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 03/01/2023 |
New England Eye Center
 New England Eye Center Medical/Nursing ServicesHealth Services Provides ophthalmology care services | Corporate Officer/Principal | 01/01/1998 |
Formation de Caroline Baumal
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
15
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Apellis Pharmaceuticals, Inc.
 Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New England Eye Center
New England Eye Center Medical/Nursing ServicesHealth Services Provides ophthalmology care services | Health Services |
